Skip to content

The effect of individual exercise programs under the supervision of WeChat on the health of middle-aged and elderly people with type 2 diabetes: a randomized controlled clinical trial

The effect of individual exercise programs under the supervision of WeChat on the health of middle-aged and elderly people with type 2 diabetes: a randomized controlled clinical trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078389
Enrollment
Unknown
Registered
2023-12-07
Start date
2023-12-08
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Exercise intervention group:Personalised exercise prescriptions are developed and patients are monitored weekly online via WeChat for completion of weekly exercise
Control group:Not providing exercise intervention and guidance to patients

Sponsors

Shenzhen Qianhai Shekou Free Trade Zone Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 79 Years

Inclusion criteria

Inclusion criteria: Age 45 to 79 years old, in line with the diagnostic criteria of diabetes in the 2020 CDS guidelines, and diagnosed as T2MD; T2MD with a course of 3 months or more, voluntarily joining this study and signing an informed consent form.

Exclusion criteria

Exclusion criteria: ? Those who are unwilling to participate in the intervention or cannot complete the intervention and follow-up as required; ? In severe diabetes patients, blood sugar fluctuates significantly, and the blood sugar after meal is higher than 16.7 mmol/L at random; ? Patients with complications such as acute infection or acidosis; ? Diabetes is accompanied by severe kidney disease and renal failure (creatinine Cr>1.768 mmol/L); ? Diabetes with hypertension (more than 200/100 mmHg), drug use is still not stable or posture changes, blood pressure fluctuations are large; ? Diabetes patients with serious heart disease, eye disease and diabetes foot disease; ? Individuals who have participated in other experimental studies within the past 3 months; ? People with contraindications to exercise.

Design outcomes

Primary

MeasureTime frame
Glycosylated hemoglobin;Weight;Fasting blood glucose;

Secondary

MeasureTime frame
Body composition;Grip;Balance;Flexibility;Quiet heart rate;Height;Blood pressure;

Countries

China

Contacts

Public ContactShaofen Huang

Shenzhen Qianhai Shekou Free Trade Zone Hospital

shaofenhuang@126.com+86 136 3256 7682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026